SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
OPEXA THERAPEUTICS INC
(NQSC:OPXA Last Sale: 1.71 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (OPXA : $1.71)
$32 million Market Cap at September 12, 2013
Employs 40.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
2635 N. Crescent Ridge Drive Research Report Earnings Snapshot - Last 11/06/18
The Woodlands, TX 77381 Fact Sheet
Phone: (281) 272-9331 Financial Statements
Peer Comparison
Annual Reports

Neil K. Warma, CEO/Pres., Lynne Hohlfeld, CFO
Indicated successful outcome of two FDA meetings regarding Tovaxin, a personalized T-cell therapeutic vaccine, and the first ever personalized T-cell therapy for MS patients, and a well defined path forward for Phase 3 clinical studies, January 5, 2011. Transfer to Nasdaq September 1, 2006. Formerly PHARMAFRONTIERS CORP until October 2005. Founded in 2003.
Historical Charts    Technical Analysis
No Historical Data available for OPXA

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common OPXA $1.71 $ 0 $1.6 $1.77 1,721,279 $1.07 $5.19 18,467
Warrants OPXAW $1.14 $ 0 $1.1 $1.14 850 $ $ 7,644
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10128
Common Stock $31,579

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
01-SEP-06 SPTA Symbol Changed to OPXA
21-FEB-01 SPTAE Symbol Changed to SPTA
11-DEC-00 SPTA Symbol Changed to SPTAE

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex